DXCM vs INTS
DexCom Inc (DXCM) versus Intensity Therapeutics, Inc. Common stock (INTS) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Latest reported DXCM revenue for 2024-12-31 was $4.03B. Net income was $576.2M. Revenue was up 11.3% from 2023-12-31 to 2024-12-31. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
INTS does not have a complete income-statement cache yet.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. INTS currently screens at market cap $7.7M.
Not investment advice. Open the DXCM and INTS stock pages for the full models.
Not investment advice.